Biotest AG
OTC: BIESF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jorg Schuttrumpf
- Employees
- 2,495
- Headquarters
- Dreieich, Germany
- IPO year
- 2014
- Market cap
- $1.6B
- Website
- https://www.biotest.com
Loading BIESF…
Loading profile data…Frequently asked questions about BIESF
What does Biotest AG (BIESF) do?
Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass...
Where does BIESF trade?
Biotest AG (BIESF) trades on the Other OTC.
What sector is BIESF in?
Biotest AG (BIESF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biotest AG?
Jorg Schuttrumpf is the chief executive officer of Biotest AG (BIESF).
Where is Biotest AG headquartered?
Biotest AG is headquartered in Germany.
Does BIESF pay a dividend?
Yes — Biotest AG (BIESF) paid a trailing twelve-month dividend of USD 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIESF go public?
Biotest AG (BIESF) completed its initial public offering in 2014.